𩺠å
§ç§å°ç§èåç
1ïžâ£ 22E æŽæ°
- Autoimmune encephalitis recognition: > 10 specific antibodies described; panel testing essential
- Metagenomic NGS (e.g., Chan Zuckerberg Biohub clinical mNGS): identifies rare/unknown pathogens â used at major centers for unknown encephalitis
- EEG in HSV encephalitis: PLEDs (periodic lateralized epileptiform discharges) â characteristic
- Tecovirimat for mpox encephalitis (rare CNS involvement)
2ïžâ£ Clinical Approach
ç¶é© management at admission
- Acyclovir 10 mg/kg q8h IV ASAP (HSV)
- Empirical bacterial meningitis cover: ceftriaxone + vancomycin (until LP rules out)
- Anti-seizure (levetiracetam) if seizure
- ICU if severe (intubation, ICP management)
- HSV PCR + viral panel + autoimmune Ab panel + MRI + EEG
When to stop acyclovir
- HSV PCR negative à 2 (48-72 hr apart) + clinical improvement + alternative diagnosis confirmed â stop
- Otherwise complete 14-21 days
3ïžâ£ å°ç£ context
- JEV endemic â vaccine in childhood schedule
- Enterovirus 71 encephalitis (å
ç«¥) â 1998 epidemic; supportive
- Dengue encephalitis: rare but reported in severe cases
- Tick-borne encephalitis: not common in Taiwan
- Rabies: èª 2013 èµ·éçåç© (錬çŸ) rabies åæµ; post-exposure vaccine åŒ·çæšèŠ